Topiramate treatment for alcoholic outpatients recently receiving residential treatment programs: A 12-week, randomized, placebo-controlled trial

Drug and Alcohol Dependence

Volumn 133, Issue 2, 2013, Pages 440-446

  Likhitsathian, Surinporn ^a   Uttawichai, Kanok ^b   Booncharoen, Hathaichonnee ^c   Wittayanookulluk, Apisak ^a   Angkurawaranon, Chaisiri ^a   Srisurapanont, Manit ^a  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b Chiang Mai Ram Hospital   (Thailand)

^c Saunprung Hospital   (Thailand)

Author keywords

Alcohol; Detoxification; Inpatient; Placebo; Residential; Topiramate

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; PLACEBO; TOPIRAMATE;

ADULT; ALCOHOL WITHDRAWAL; ALCOHOLISM; APPETITE DISORDER; ARTHRALGIA; ARTICLE; BACKACHE; CONCENTRATION LOSS; CONTROLLED STUDY; DETOXIFICATION; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DSM-IV; FATIGUE; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEADACHE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; OUTCOME ASSESSMENT; OUTPATIENT; PARESTHESIA; PATIENT COMPLIANCE; PRIORITY JOURNAL; PRURITUS; PSYCHOMOTOR RETARDATION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RESIDENTIAL CARE; SENSITIVITY ANALYSIS; SIDE EFFECT; SOMNOLENCE; SURVIVAL; TASTE DISORDER; TASTE PERVERSION; TONGUE NUMBNESS; TREATMENT DURATION; TREMOR; WITHDRAWAL SYNDROME;

ALCOHOL; DETOXIFICATION; INPATIENT; PLACEBO; RESIDENTIAL; TOPIRAMATE;

ADULT; ALCOHOLISM; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; FRUCTOSE; HUMANS; MALE; MIDDLE AGED; MOTIVATIONAL INTERVIEWING; NEUROPROTECTIVE AGENTS; OUTPATIENTS; PATIENT COMPLIANCE; RECURRENCE; RESIDENTIAL TREATMENT; TREATMENT OUTCOME;

EID: 84887026434     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2013.06.032     Document Type: Article

References (24)

1. American Psychiatric Association American Psychiatric Association Practice Guidelines for the Treatment of Psychiatric Disorders. Compendium 2006 2006, American Psychiatric Association, Arlington, VA.
2. Assanangkornchai S., Saunders J.B., Conigrave K.M. Patterns of drinking in Thai men. Alcohol Alcohol. 2000, 35:263-269.
3. Baltieri D.A., Daro F.R., Ribeiro P.L., de Andrade A.G. Comparing topiramate with naltrexone in the treatment of alcohol dependence. Addiction 2008, 103:2035-2044.
4. Barth K.S., Malcolm R.J. Disulfiram: an old therapeutic with new applications. CNS Neurol. Disord. Drug Targets 2010, 9:5-12.
5. Bergkvist L., Rossiter J.R. The predictive validity of multiple-item versus single-item measures of the same constructs. J. Mark. Res. 2007, 44:175-184.
6. Black D. Treatment for Antisocial Personality Disorder 2006, http://psychcentral.com/lib/2006/treatment-for-antisocial-personality-disorder (accessed 31.01.13).
7. Bohn M.J., Babor T.F., Kranzler H.R. The Alcohol Use Disorders Identification Test (AUDIT): validation of a screening instrument for use in medical settings. J. Stud. Alcohol 1995, 56:423-432.
8. Carlino E., Pollo A., Benedetti F. The placebo in practice: how to use it in clinical routine. Curr. Opin. Supportive Palliat. Care 2012, 6:220-225.
9. Cohen J. A power primer. Psychol. Bull. 1992, 112:155-159.
10. Finney J.W., Hahn A.C., Moos R.H. The effectiveness of inpatient and outpatient treatment for alcohol abuse: the need to focus on meditators and moderators of settings effects. Addiction 1996, 91:1773-1796.
11. Hardon D.C., Baker D., Hodges J.S., Hicks N. Rating the quality of evidence for clinical practice guidelines. J. Clin. Epidemiol. 1996, 49:749-754.
12. Johnson B.A., Ait-Daoud N., Bowden C.L., DiClemente C.C., Roache J.D., Lawson K., Javors M.A., Ma J.Z. Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet 2003, 361:1677-1685.
13. Johnson B.A., Rosenthal N., Capece J.A., Wiegand F., Mao L., Beyers K., McKay A., Ait-Daoud N., Anton R.F., Ciraulo D.A., Kranzler H.R., Mann K., O'Malley S.S., Swift R.M. Topiramate for treating alcohol dependence: a randomized controlled trial. JAMA 2007, 298:1641-1651.
14. Kongsakon R., Silpakit C. Thai version of the medical outcome study 36 items short form health survey: an instrument for measuring clinical results in mental disorder patients. Ramathibodi Med. J. 2000, 23:8-19.
15. Kranzler H.R., Stephenson J.J., Montejano L., Wang S., Gastfriend D.R. Persistence with oral naltrexone for alcohol treatment: implications for healthcare utilization. Addiction 2008, 103:1801-1808.
16. Mark T.L., Kassed C.A., Vandivort-Warren R., Levit K.R., Kranzler H.R. Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty. Drug Alcohol Depend. 2009, 99:345-349.
17. Peduzzi P., Henderson W., Hartigan P., Lavori P. Analysis of randomized controlled trial. Epidemiol. Rev. 2002, 24:26-38.
18. Rossegger A., Keller A., Odenwald M., Endrass J. The appropriateness of the treatment setting for the inpatient post-acute treatment of alcohol dependence disorders in Switzerland. Int. J. Ment. Health Syst. 2009, 3:16.
19. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., Dunbar G.C. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 1998, 59(Suppl. 20):22-33.
20. Sloan J.A., Aaronson N., Cappelleri J.C., Fairclough D.L., Varricchio C. Assessing the Clinical Significance of Single Items Relative to Summated Scores. Mayo Clin. Proc. 2002, 77:479-487.
21. Sobell L.C., Sobell M.B. Timeline Follow-back: a technique for assessing self-reported alcohol consumption. Measuring Alcohol Consumption: Psychosocial and Biological Methods 1992, 41-72. Humana Press, Towota, NJ. R.Z. Litten, J. Allen (Eds.).
22. Sullivan J.T., Sykora K., Schneiderman J., Naranjo C.A., Sellers E.M. Assessment of alcohol withdrawal: the revised Clinical Institute Withdrawal Assessment for Alcohol scale (CIWA-Ar). Br. J. Addict. 1989, 84:1353-1357.
23. Ware J., Sherbourne C. The MOS 36-Item Short Form Health Survey (SF-36). I: conceptual framework and item selection. Med. Care 1992, 30:473-483.
24. Ware J., Snow K., Kosinski M., Gandek B. SF-36 Health Survey Manual and Interpretation Guide 1993, The Health Institute, Boston, MA.